|
TDP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.841400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.648400E-01 |
| Normal-vs-Stage2 |
4.064800E-01 |
| Normal-vs-Stage3 |
5.439800E-01 |
| Normal-vs-Stage4 |
1.459150E-01 |
| Stage1-vs-Stage2 |
1.080360E-01 |
| Stage1-vs-Stage3 |
8.792400E-01 |
| Stage1-vs-Stage4 |
1.182040E-02 |
| Stage2-vs-Stage3 |
2.063000E-01 |
| Stage2-vs-Stage4 |
6.738000E-01 |
| Stage3-vs-Stage4 |
4.746200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.256400E-01 |
| Normal-vs-AfricanAmerican |
7.211600E-01 |
| Normal-vs-Asian |
6.258800E-01 |
| Caucasian-vs-AfricanAmerican |
9.019000E-01 |
| Caucasian-vs-Asian |
8.826600E-01 |
| AfricanAmerican-vs-Asian |
9.900000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.616800E-01 |
| Normal-vs-Female |
7.702800E-01 |
| Male-vs-Female |
6.792800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.580800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.998400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.434800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.835000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.957600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.919800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.640400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.604600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.393400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.475200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.205360E-01 |
| Classical-VS-Follicular |
3.953600E-04 |
| Classical-VS-Other |
2.806200E-01 |
| Classical-VS-Normal |
1.581020E-01 |
| Tall-VS-Follicular |
4.846600E-01 |
| Tall-VS-Other |
7.771800E-01 |
| Tall-VS-Normal |
6.700400E-01 |
| Follicular-VS-Other |
9.086600E-01 |
| Follicular-VS-Normal |
1.564640E-01 |
| Other-VS-Normal |
5.794000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.807800E-01 |
| Normal-vs-N1 |
2.661400E-01 |
| N0-vs-N1 |
2.152600E-01 |
|
|
